Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tajinder P. Singh, M.D., M.B.,B.S.

Co-Author

This page shows the publications co-authored by Tajinder Singh and Kimberlee Gauvreau.
Connection Strength

12.429
  1. Matching Donor and Recipient Size in Pediatric Heart Transplantation. Transpl Int. 2022; 35:10226.
    View in: PubMed
    Score: 0.985
  2. Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant. J Am Heart Assoc. 2021 07 06; 10(13):e021082.
    View in: PubMed
    Score: 0.945
  3. Characteristics Associated With High-Performing Pediatric Heart Transplant Centers in the United States From 2006 to 2015. JAMA Netw Open. 2020 11 02; 3(11):e2023515.
    View in: PubMed
    Score: 0.903
  4. Long-Term Survival After Heart Transplantation at Centers Stratified by Short-Term Performance. Circ Heart Fail. 2019 11; 12(11):e005914.
    View in: PubMed
    Score: 0.844
  5. Reply to the letter: "Center effect on posttransplant survival among currently active United States pediatric heart transplant centers". Am J Transplant. 2018 12; 18(12):3080.
    View in: PubMed
    Score: 0.785
  6. Center effect on posttransplant survival among currently active United States pediatric heart transplant centers. Am J Transplant. 2018 12; 18(12):2914-2923.
    View in: PubMed
    Score: 0.766
  7. Risk stratification for in-hospital mortality after heart transplantation using the modification of diet in renal disease and the chronic kidney disease epidemiology collaboration equations for estimated glomerular filtration rate. Transplantation. 2014 Nov 15; 98(9):1000-6.
    View in: PubMed
    Score: 0.597
  8. Association of hemodynamic profiles with wait-list mortality in children listed for heart transplantation with idiopathic dilated cardiomyopathy. Am J Cardiol. 2015 Jan 15; 115(2):243-8.
    View in: PubMed
    Score: 0.595
  9. Risk stratification and transplant benefit in children listed for heart transplant in the United States. Circ Heart Fail. 2013 Jul; 6(4):800-8.
    View in: PubMed
    Score: 0.539
  10. Current outcomes in US children with cardiomyopathy listed for heart transplantation. Circ Heart Fail. 2012 Sep 01; 5(5):594-601.
    View in: PubMed
    Score: 0.511
  11. Risk prediction for early in-hospital mortality following heart transplantation in the United States. Circ Heart Fail. 2012 Mar 01; 5(2):259-66.
    View in: PubMed
    Score: 0.492
  12. Trends in wait-list mortality in children listed for heart transplantation in the United States: era effect across racial/ethnic groups. Am J Transplant. 2011 Dec; 11(12):2692-9.
    View in: PubMed
    Score: 0.478
  13. Improved survival in heart transplant recipients in the United States: racial differences in era effect. Circ Heart Fail. 2011 Mar; 4(2):153-60.
    View in: PubMed
    Score: 0.457
  14. Improved survival in pediatric heart transplant recipients: have white, black and Hispanic children benefited equally? Am J Transplant. 2011 Jan; 11(1):120-8.
    View in: PubMed
    Score: 0.457
  15. Socioeconomic position, ethnicity, and outcomes in heart transplant recipients. Am J Cardiol. 2010 Apr 01; 105(7):1024-9.
    View in: PubMed
    Score: 0.429
  16. Determinants of heart rate recovery following exercise in children. Med Sci Sports Exerc. 2008 Apr; 40(4):601-5.
    View in: PubMed
    Score: 0.377
  17. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Transplantation. 2020 01; 104(1):e31-e37.
    View in: PubMed
    Score: 0.213
  18. Is Doppler echocardiography useful for estimating left ventricular filling pressures in pediatric heart transplant recipients? Pediatr Transplant. 2019 11; 23(7):e13543.
    View in: PubMed
    Score: 0.206
  19. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients. J Heart Lung Transplant. 2019 06; 38(6):601-608.
    View in: PubMed
    Score: 0.200
  20. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? Circ Heart Fail. 2016 Jan; 9(1):e002328.
    View in: PubMed
    Score: 0.161
  21. Tissue Doppler imaging for rejection surveillance in pediatric heart transplant recipients. J Heart Lung Transplant. 2013 Oct; 32(10):1027-33.
    View in: PubMed
    Score: 0.137
  22. Prognostic value of exercise testing during heart transplant evaluation in children. Circ Heart Fail. 2013 Jul; 6(4):792-9.
    View in: PubMed
    Score: 0.134
  23. Cardiac allograft function during the first year after transplantation in rejection-free children and young adults. Circ Cardiovasc Imaging. 2012 Nov; 5(6):756-64.
    View in: PubMed
    Score: 0.129
  24. A risk-prediction model for in-hospital mortality after heart transplantation in US children. Am J Transplant. 2012 May; 12(5):1240-8.
    View in: PubMed
    Score: 0.123
  25. Association of graft ischemic time with survival after heart transplant among children in the United States. J Heart Lung Transplant. 2011 Nov; 30(11):1244-9.
    View in: PubMed
    Score: 0.118
  26. Recovery of oxygen consumption after maximal exercise in children. Med Sci Sports Exerc. 2011 Apr; 43(4):555-9.
    View in: PubMed
    Score: 0.116
  27. Impact of ABO-incompatible listing on wait-list outcomes among infants listed for heart transplantation in the United States: a propensity analysis. Circulation. 2010 May 04; 121(17):1926-33.
    View in: PubMed
    Score: 0.109
  28. Racial and ethnic differences in mortality in children awaiting heart transplant in the United States. Am J Transplant. 2009 Dec; 9(12):2808-15.
    View in: PubMed
    Score: 0.105
  29. Socioeconomic position and graft failure in pediatric heart transplant recipients. Circ Heart Fail. 2009 May; 2(3):160-5.
    View in: PubMed
    Score: 0.101
  30. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009 Feb 10; 119(5):717-727.
    View in: PubMed
    Score: 0.100
  31. Longitudinal changes in heart rate recovery after maximal exercise in pediatric heart transplant recipients: evidence of autonomic re-innervation? J Heart Lung Transplant. 2007 Dec; 26(12):1306-12.
    View in: PubMed
    Score: 0.092
  32. Comparison of tissue Doppler imaging and conventional echocardiography to discriminate rejection from non-rejection after pediatric heart transplantation. Pediatr Transplant. 2020 08; 24(5):e13738.
    View in: PubMed
    Score: 0.055
  33. Impact of medication non-adherence on survival after pediatric heart transplantation in the U.S.A. J Heart Lung Transplant. 2013 Sep; 32(9):881-8.
    View in: PubMed
    Score: 0.034
  34. Extracorporeal membrane oxygenation for bridge to heart transplantation among children in the United States: analysis of data from the Organ Procurement and Transplant Network and Extracorporeal Life Support Organization Registry. Circulation. 2011 Jun 28; 123(25):2975-84.
    View in: PubMed
    Score: 0.029
  35. Factors associated with in-hospital mortality in infants undergoing heart transplantation in the United States. J Thorac Cardiovasc Surg. 2011 Feb; 141(2):531-6, 536.e1.
    View in: PubMed
    Score: 0.029
  36. Outcomes of heart transplantation using donor hearts from infants with sudden infant death syndrome. J Heart Lung Transplant. 2010 Nov; 29(11):1226-30.
    View in: PubMed
    Score: 0.028
  37. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant. 2009 Dec; 28(12):1292-8.
    View in: PubMed
    Score: 0.026
  38. Association of socioeconomic position and medical insurance with fetal diagnosis of critical congenital heart disease. Circ Cardiovasc Qual Outcomes. 2009 Jul; 2(4):354-60.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.